10.09.2015 • NewsDede WillamsCeltic RenewablesGrangemouth

Grangemouth Biofuels Plan Gets £11 Million Grant

Plans by Edinburgh-based Celtic Renewables to build a new plant in Grangemouth, Scotland, that would produce biobutanol from Scotch whisky byproducts, has received an £11 million boost from the UK Department of Transport.

Celtic Renewables said it has already attracted investment and partners in the private sector to fund a demonstration plant producing the biobutanol, used as an alternative fuel for automobiles and airplanes. The transport department funding would facilitate construction of a demonstration plant that could be scaled up to industrial production.

The company is still searching for a suitable location in the Grangemouth area for the demonstration plant projected to be operational by the end of 2018.

Dennis Goldie, spokesperson for Falkirk Council’s economic development board, told the local newspaper Falkirk Herald: “Securing this new biofuel plant is a real coup for the area and fits with our long-term goals to encourage investment in Grangemouth and to create and sustain a booming local economy.

Grangemouth currently is highly dependent on the sprawling Ineos-owned petrochemical complex to provide jobs, and the biofuels project would provide a clear contrast.

The estimated £25 million biofuels construction project offers an impetus “for a range of local businesses,” Goldie said. The plant would at least employ 25 full time workers in highly skilled posts such as chemists, engineers and plant operators.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.